Internal Medicine, Endocrinology, Diabetes, & Metabolism · Blue Springs, MO
NPI
1932145448
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
600 NE Adams Dairy Pkwy
Blue Springs, MO, 64014
Phone (816) 347-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
3,187 services
Medicare patients, 2024
658
Average age 73
Drug cost, 2024
$5.4M
10,993 prescriptions
Company payments, 2025
$37.05
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Renato M Sandoval was code 99214 (office e&m - established), 1,001 times for 447 patients. In total Renato M Sandoval billed 3,187 services in 15 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,001 | 447 | $86.10 | $86K |
| 83036 Blood Count | Office | 851 | 405 | $9.45 | $8,042 |
| 95251 Test - Miscellaneous | Office | 490 | 204 | $24.88 | $12K |
| 99213 Office E&M - Established | Office | 217 | 178 | $57.08 | $12K |
| 99204 Office E&M - New | Office | 68 | 68 | $113.68 | $7,730 |
By year: 2022 $194K for 6,296 services; 2023 $156K for 4,508 services; 2024 $128K for 3,187 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 851 | 405 | $9.45 | $8,042 |
Medicare prescription drug claims, 2024
In 2024, the drug Renato M Sandoval prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,042 prescriptions and refills. In total Renato M Sandoval wrote 10,993 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,042 | 1,499 | 211 | $1.4M |
| Metformin Hcl Er Metformin Hcl | 1,023 | 2,707 | 287 | $11K |
| Jardiance Empagliflozin | 868 | 1,647 | 199 | $944K |
| Levothyroxine Sodium Generic | 862 | 2,087 | 228 | $7,379 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 591 | 1,297 | 164 | $89K |
| Mounjaro Tirzepatide | 553 | 737 | 108 | $783K |
| Metformin Hcl Generic | 303 | 790 | 85 | $2,994 |
| Glimepiride Generic | 285 | 817 | 94 | $1,999 |
| Humalog Kwikpen U-100 Insulin Lispro | 227 | 479 | 70 | $90K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 200 | 358 | 38 | $174K |
| Tresiba Flextouch U-100 Insulin Degludec | 196 | 463 | 65 | $165K |
| Pioglitazone Hcl Generic | 193 | 515 | 51 | $2,524 |
| Novolog Flexpen Insulin Aspart | 192 | 389 | 73 | $65K |
| Atorvastatin Calcium Generic | 177 | 480 | 52 | $2,016 |
| Trulicity Dulaglutide | 171 | 260 | 39 | $251K |
Brand drugs: 6,170 claims; generic drugs: 4,124 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Renato M Sandoval $37.05 ($37.05 in general payments such as food, travel and fees) from 2 companies. The largest payer was Tandem Diabetes Care, Inc. with $22.38.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.